Vimarsana
Biggest News Aggregation in the World

Page 4 - Bracanalysis Cdx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bracanalysis Cdx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bracanalysis Cdx Today - Breaking & Trending Today

Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program - Vimarsana News

Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

New program will increase access to affordable genetic testing while also helping to identify and elevate high-risk patient careSALT LAKE CITY, April 12, 2023 -- Myriad Genetics, Inc., a leader... | April 12, 2023

Myriad Genetics Patient Outcomes Study Shows RiskScore - Vimarsana News

Myriad Genetics Patient Outcomes Study Shows RiskScore

Myriad’s MyRisk™ Hereditary Cancer test with RiskScore® provides a personalized breast cancer risk assessment for women of all ancestries...

GeneSight Mental Health Monitor Reveals Gap on the Front - Vimarsana News

GeneSight Mental Health Monitor Reveals Gap on the Front

Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care...

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries - Vimarsana News

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

SALT LAKE CITY, Nov. 03, 2022 -- Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced today JCO Precision Oncology has published a study1 that highlights the... | November 3, 2022

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries - Vimarsana News

New Study Published in JCO Precision Oncology Features Data Validating Personalized Breast Cancer Risk Assessments for Women of All Ancestries

03.11.2022 - SALT LAKE CITY, Nov. 03, 2022 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced today JCO Precision Oncology has published a study1 that highlights the development and ...